Esbriet and Krill oil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Esbriet (pirfenidone) and Krill oil (krill oil). Common drug interactions include malaise among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Esbriet and Krill oil. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Esbriet?

Esbriet has active ingredients of pirfenidone. eHealthMe is studying from 39,858 Esbriet users. Check the latest studies of Esbriet.

What is Krill oil?

Krill oil has active ingredients of krill oil. It is often used in high blood cholesterol. eHealthMe is studying from 5,042 Krill oil users. Check the latest studies of Krill oil.



On Jul, 09, 2026

21 people who take Esbriet and Krill oil together, and have interactions are studied.

Esbriet and Krill oil drug interactions.

What are the common drug interactions of Esbriet and Krill Oil, by gender? *:

female:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Diarrhoea
  3. Dyspepsia (indigestion)
  4. Weight decreased
  5. Decreased appetite
  6. Nausea (feeling of having an urge to vomit)
  7. Asthenia (weakness)
  8. Dizziness
  9. Dysphonia (speech disorder attributable to a disorder of phonation)
  10. Pulmonary oedema (fluid accumulation in the lungs)

male:

  1. Rash
  2. Cough
  3. Decreased appetite
  4. Heart rate increased
  5. Infection
  6. Lower respiratory tract infection
  7. Muscle spasms (muscle contraction)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Oxygen saturation decreased
  10. Skin burning sensation

What are the common drug interactions of Esbriet and Krill Oil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Rash
  3. Cataract (clouding of the lens inside the eye)
  4. Heart rate increased
  5. Infection
  6. Lower respiratory tract infection
  7. Muscle spasms (muscle contraction)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Oxygen saturation decreased
  10. Skin burning sensation

What are the existing conditions these people have? *

  1. Idiopathic Pulmonary Fibrosis (chronic lung disease): 19 people, 90.48%
  2. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 14.29%
  3. Hypersensitivity: 2 people, 9.52%
  4. Cough: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Esbriet and Krill oil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Esbriet and Krill oil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Esbriet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Krill oil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Esbriet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Krill oil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pirfenidone and krill oil (the active ingredients of Esbriet and Krill oil, respectively), and Esbriet and Krill oil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: